| 标题 |
Loss of CD99L2 Contributed to Temozolomide Resistance and Glioblastoma Tumorigenesis Based on Genome-scale CRISPR/Cas9 Screening |
| 网址 | |
| DOI |
10.2174/0113816128386002250701113848
doi
|
| 其它 |
期刊:Current Pharmaceutical Design 作者:Zeen Sun; Manhua Cui; Zhenghao Deng; Lu Zhou; Feiyue Zeng; et al 出版日期:2025-07-18 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)